niacinamide has been researched along with Lymphoma, Mantle-Cell in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Lymphoma, Mantle-Cell: A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib signaling was characterized by quantitative PCR, Western blotting, immunofluorescence, and protein immunoprecipitation." | 1.39 | Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma. ( Campo, E; Colomer, D; López-Guerra, M; Montraveta, A; Navarro, A; Pérez-Galán, P; Rosich, L; Roué, G; Saborit-Villarroya, I; Xargay-Torrent, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tarantelli, C | 1 |
| Zhang, L | 1 |
| Curti, E | 1 |
| Gaudio, E | 1 |
| Spriano, F | 1 |
| Priebe, V | 1 |
| Cascione, L | 1 |
| Arribas, AJ | 1 |
| Zucca, E | 1 |
| Rossi, D | 1 |
| Stathis, A | 1 |
| Bertoni, F | 1 |
| Xargay-Torrent, S | 1 |
| López-Guerra, M | 1 |
| Montraveta, A | 1 |
| Saborit-Villarroya, I | 1 |
| Rosich, L | 1 |
| Navarro, A | 1 |
| Pérez-Galán, P | 1 |
| Roué, G | 1 |
| Campo, E | 1 |
| Colomer, D | 1 |
2 other studies available for niacinamide and Lymphoma, Mantle-Cell
| Article | Year |
|---|---|
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Combined Chemotherapy Protocols; Bridge | 2019 |
Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma.
Topics: Actins; Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Movement; Chemok | 2013 |